Richard F. Clark

Richard F. Clark

Auto-generated profile, based on publicly available information

Richard F. Clark

Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, CA; San Diego Division, California Poison Control System, San Diego, CA, United States of America

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SFSteve D. Fidanze
Steve D. Fidanze
SEScott Erickson
Scott Erickson
GWGary T. Wang
Gary T. Wang
RMRobert Mantei
Robert Mantei
RCRichard F. Clark
Richard F. Clark
RHRobert D. Hubbard
Robert D. Hubbard

1 January 1992 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YOYat Sun Or
Yat Sun Or
RCRichard F. Clark
Richard F. Clark
BLBenjamin Lane
Benjamin Lane
KMKarl W. Mollison
Karl W. Mollison
GCGeorge W. Carter
George W. Carter
JLJay R. Luly
Jay R. Luly


1 January 1996 in Journal of Toxicology: Clinical Toxicology
Verified
Journal Article
Closed access
PDF file
SNSean P. Nordt
Sean P. Nordt
SWSaralyn R. Williams
Saralyn R. Williams
STSteven Turchen
Steven Turchen
AMAnthony Manoguerra
Anthony Manoguerra
DSDavid Smith
David Smith
RCRichard F. Clark
Richard F. Clark
Case Report: Hypermagnesemia is a rare condition that commonly follows excessive therapeutic administration of magnesium sulfate to treat eclampsia of pregnancy. Signs and symptoms of this condition include extreme muscle weakness, loss of deep tendon reflexes, mental status depression, and cardiac dysrhythmias. Clinically significant hypermagnesemia following oral or rectal administration of magnesium containing products in patients with normal renal function is rare. We report a case of hypermagnesemia following massive Epsom salt ingestion that resulted in extreme musculoskeletal weakness and altered mentation.

15 November 2021 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
HLHong Li
Hong Li
TDTeresa Dodd-Butera
Teresa Dodd-Butera
MBMargaret L. Beaman
Margaret L. Beaman
MPMolly Broderick Pritty
Molly Broderick Pritty
THThomas E. Heitritter
Thomas E. Heitritter
RCRichard F. Clark
Richard F. Clark
Despite significant prevention efforts, childhood poison exposures remain a serious public health challenge in the United States. This study aimed to assess annual trends of pharmaceutical vs. non-pharmaceutical poison exposures in the US among children 0–19 years and compare the odds of death by children’s age group. Poison exposure and fatality data were retrospectively extracted from 2009 to 2019 National Poison Data System (NPDS) annual reports for children in all reported age groups. Overall, there was a significant reduction in the annual population-adjusted poison exposures in children (annual percentage change = −2.54%, 95% CI = −3.94% to −1.15%, p < 0.01), but not in poisoning-related fatalities. Children 0–5 had similar odds of dying from exposure to non-pharmaceuticals vs. pharmaceuticals. The odds of children 6–12 dying from non-pharmaceuticals vs. pharmaceuticals was 2.38 (95% CI = 1.58, 3.58), χ2 = 18.53, p < 0.001. In contrast, the odds of children 13–19 dying from pharmaceuticals vs. non-pharmaceuticals was 3.04 (95% CI = 2.51, 3.69), χ2 = 141.16, p < 0.001. Suicidal intent accounted for 40.63% of pharmaceutical deaths in children 6–12, as well as 48.66% of pharmaceutical and 31.15% of non-pharmaceutical deaths in children 13–19. While a significant decline in overall childhood poison exposures was reported, a decrease in poisoning-related fatalities was not observed. Children in different age groups had contrasting relative odds of death from pharmaceutical and non-pharmaceutical exposures. Among older children, a greater proportion of poisoning-related deaths was due to intentional suicide. These findings provide evidence of age-specific trends in childhood poison exposure risk and directions for future poison prevention efforts and behavioral health partnerships.

2 October 2023 in The American Journal of Emergency Medicine
Verified
Journal Article
Open access
JHJeremy Hardin
Jeremy Hardin
HGHenrik Galust
Henrik Galust
ABAlexandra Bensel
Alexandra Bensel
SBShane Bierly
Shane Bierly
JSJustin Seltzer
Justin Seltzer
CCColleen Campbell
Colleen Campbell
A 48-year-old male intentionally ingested "gopher killer" containing strychnine as a, suicide attempt. He rapidly developed generalized muscle spasms with opisthotonos followed by cardiovascular collapse. He was resuscitated, treated with 24 h of, neuromuscular paralysis, and was discharged on hospital day 10 without sequelae. A blood strychnine concentration obtained five hours post ingestion was 2.2 mg/L. Strychnine poisoning is exceedingly rare in the modern United States and this report contains a video recording of the classic exam findings.